Institute of Clinical Biochemistry and Diagnostics, Medical Faculty of Charles University and Faculty Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic.
Clin Transl Oncol. 2013 Feb;15(2):160-3. doi: 10.1007/s12094-012-0894-z. Epub 2012 Jul 19.
Ovarian cancer is a leading cause of death from gynecologic tumors, however, the molecular and especially epigenetic events underlying this transformation are poorly understood. Promoter methylation status of tumor suppressor genes may be associated with transcriptional silencing and tumor progression. It has been shown that methylation of CpG dinucleotides located in the promoter region of p53 is associated with low expression levels of this gene. The aim of this study was to investigate promoter methylation of p53 gene in ovarian cancer by comparison with normal ovarian tissue.
To search for promoter methylation of p53 gene we used methylation-specific PCR (MSP) to compare the methylation status of 66 tissue samples of ovarian cancer with 37 control samples.
In our study methylation specific PCR revealed p53 promoter methylation in 34 of 66 (51.5 %) of specimens with ovarian cancer.
These results indicate that methylation in p53 promoter region may play an important role in carcinogenesis of ovarian cancer and could potentially be used in screening of ovarian cancer, and may have implications for future chemotherapy based on epigenetic changes.
卵巢癌是妇科肿瘤死亡的主要原因,但这种转化背后的分子,特别是表观遗传事件知之甚少。肿瘤抑制基因启动子甲基化状态可能与转录沉默和肿瘤进展有关。已经表明,位于 p53 启动子区域的 CpG 二核苷酸的甲基化与该基因的低表达水平有关。本研究旨在通过与正常卵巢组织比较,研究卵巢癌中 p53 基因的启动子甲基化。
为了寻找 p53 基因的启动子甲基化,我们使用甲基化特异性 PCR(MSP)比较了 66 例卵巢癌组织样本和 37 例对照样本的甲基化状态。
在我们的研究中,甲基化特异性 PCR 显示 66 例卵巢癌标本中有 34 例(51.5%)存在 p53 启动子甲基化。
这些结果表明,p53 启动子区域的甲基化可能在卵巢癌的癌变过程中起重要作用,并可能用于卵巢癌的筛查,并且可能对基于表观遗传变化的未来化疗具有重要意义。